Single‐cell analysis of MYD88L265P and MYD88WT Waldenström macroglobulinemia patients
Abstract Waldenström macroglobulinemia (WM) is characterized by the expansion of clonal lymphoplasmacytic cells; the MYD88L265P somatic mutation is found in >90% of patients, but malignant B cells may still display intra‐clonal heterogeneity. To assess clonal heterogeneity in WM, we generated and...
Main Authors: | Tina Bagratuni, Foteini Aktypi, Ourania Theologi, Maria Sakkou, Kleio Maria Verrou, Nefeli Mavrianou‐Koutsoukou, Dimitrios Patseas, Christine Liacos, Stamatia Skourti, Alexandra Papadimou, Kostantina Taouxi, Foteini Theodorakakou, Georgios Kollias, Petros Sfikakis, Evangelos Terpos, Meletios A. Dimopoulos, Efstathios Kastritis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-02-01
|
Series: | HemaSphere |
Online Access: | https://doi.org/10.1002/hem3.27 |
Similar Items
-
P834: MULTIPARAMETRIC FLOW CYTOMETRY FOR THE DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH IGM MONOCLONAL GAMMOPATHIES
by: Ioannis Kostopoulos, et al.
Published: (2023-08-01) -
Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas
by: Xia Liu, et al.
Published: (2020-01-01) -
MyD88 contribution to ocular surface homeostasis.
by: Rose Y Reins, et al.
Published: (2017-01-01) -
Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-myddosome assembly.
by: George, J, et al.
Published: (2011) -
Blocking MyD88 signaling with MyD88 inhibitor prevents colitis-associated colorectal cancer development by maintaining colonic microbiota homeostasis
by: Bin Xie, et al.
Published: (2023-12-01)